Olive Kearins
- Cancer Research top 2%
- Breast Cancer Treatment Studies 30
- Oncology top 5%
- Global Cancer Incidence and Screening 47
- Colorectal Cancer Screening and Detection 13
- Cancer Risks and Factors 11
-
- Breast Lesions and Carcinomas 18
-
- Breast Implant and Reconstruction 7
-
- AI in cancer detection 5
-
- BRCA gene mutations in cancer 4
- Co-authors
- Gill LawrenceMatthew WallisDavid DodwellNancy TappendenGordon WishartCarlos CaldasDavid GreenbergJem Rashbass
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Olive Kearins
54 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 883
- Oncology 898
- Pathology and Forensic Medicine 452
- Radiology, Nuclear Medicine and Imaging 227
- Health Informatics 10
Countries citing papers authored by Olive Kearins
This map shows the geographic impact of Olive Kearins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olive Kearins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olive Kearins more than expected).
Fields of papers citing papers by Olive Kearins
This network shows the impact of papers produced by Olive Kearins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olive Kearins. The network helps show where Olive Kearins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olive Kearins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2022 | 21 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 9 | |
| 7 | 2019 | 2 | |
| 8 | 2018 | 66 | |
| 9 | 2018 | 4 | |
| 10 | 2018 | 19 | |
| 11 | 2015 | 9 | |
| 12 | 2014 | 18 | |
| 13 | 2014 | 23 | |
| 14 | 2013 | 3 | |
| 15 | 2011 | 62 | |
| 16 | 2010 | 283 | |
| 17 | 2010 | 45 | |
| 18 | 2009 | 4 | |
| 19 | 2008 | 7 | |
| 20 | 2008 | 182 |
About Olive Kearins
Olive Kearins is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 56 papers that have together received 1.7k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (47 papers), Breast Cancer Treatment Studies (30 papers), Breast Lesions and Carcinomas (18 papers), Colorectal Cancer Screening and Detection (13 papers), Cancer Risks and Factors (11 papers), Breast Implant and Reconstruction (7 papers), AI in cancer detection (5 papers) and BRCA gene mutations in cancer (4 papers). The work is most often cited by research in Cancer Research (883 citations), Oncology (898 citations) and Pathology and Forensic Medicine (452 citations). Olive Kearins has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Gill Lawrence, Matthew Wallis, David Dodwell, Nancy Tappenden, Gordon Wishart, Carlos Caldas, David Greenberg, Jem Rashbass, Elizabeth M. Azzato and Stephen W. Duffy. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.